Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Galderma R&D
NCT07058883 · Acne Scars
NCT07368764 · Acne, Acne Scars
NCT07151599 · Acne Scars
NCT05362929 · Acne Scars - Mixed Atrophic and Hypertrophic, Hyperpigmentation, and more
NCT05987319 · Wrinkle, Fine Lines, and more
Manisha PATEL
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions